Javascript must be enabled to continue!
Comparison of Intermittent vs. Continuous Phototherapy in the treatment of Non-Haemolytic Neonatal Hyperbilirubinemia
View through CrossRef
Introduction: Phototherapy is used in the treatment of hyperbilirubinemia in initial life-span of neonates. Our objective was the comparison of continuous vs intermittent phototherapy in the reduction of total serum bilirubin, bilirubin decrease rate, phototherapy time and hospital stay in non-haemolytic hyperbilirubinemia neonates. Place and Duration: The study was conducted at department of Pediatric medicine in Qazi Hussain Ahmad Medical Complex, Nowshera for the duration of six months from 16th January 2021 to 15th July 2021. Methods: The study involved 160 neonates with birth weight ≥2000 gm and age was above 34 weeks. They were randomly assigned to group A who were given continuous phototherapy for 3hrs and 50 mints and then rest for 45mints and group B who were given intermittent phototherapy for 3 hours and then rest for next 3 hours and so on. The levels of TSB were calculated in both groups and their comparison was made at every 12, 24 and 48 hrs after the start of phototherapy. Results: The mean of total serum bilirubin on admission was 16.01 ± 3.91 mg / dL for the continuous group and 15.21 ± 1.12 mg / dL for the intermittent group. The TSB mean after 12, 24 and 48 hrs. for continuous phototherapy was 13.30 ± 2.3 mg / dl, 11.1 ± 2.01 mg / dl, 9.26 ± 0.92 mg / dl and 13.1 ± 1.70 mg / dL, 9.54 ± 1.7 mg / dL, 8.9 ± 0.61 mg / dl (p <0.05) for the intermittent group, respectively. The mean rate of decrease in serum concentration of bilirubin was 0.30 ± 0.14 mg / dl / h in group A and 0.19 ± 0.07 mg / dl / h in group B (p = 0.5). There was no big variance between the mean hospital stay in groups A and B (p = 0.550). Conclusions: Intermittent phototherapy is a better choice than continuous phototherapy in the treatment of non-haemolytic hyperbilirubinemia, with added benefits such as less frequent disruption of the mother-child relationship and reduced radiation therapy. Keywords: Intermittent phototherapy; Continuous phototherapy; Total serum bilirubin and Neonatal hyperbilirubinemia.
Lahore Medical and Dental College
Title: Comparison of Intermittent vs. Continuous Phototherapy in the treatment of Non-Haemolytic Neonatal Hyperbilirubinemia
Description:
Introduction: Phototherapy is used in the treatment of hyperbilirubinemia in initial life-span of neonates.
Our objective was the comparison of continuous vs intermittent phototherapy in the reduction of total serum bilirubin, bilirubin decrease rate, phototherapy time and hospital stay in non-haemolytic hyperbilirubinemia neonates.
Place and Duration: The study was conducted at department of Pediatric medicine in Qazi Hussain Ahmad Medical Complex, Nowshera for the duration of six months from 16th January 2021 to 15th July 2021.
Methods: The study involved 160 neonates with birth weight ≥2000 gm and age was above 34 weeks.
They were randomly assigned to group A who were given continuous phototherapy for 3hrs and 50 mints and then rest for 45mints and group B who were given intermittent phototherapy for 3 hours and then rest for next 3 hours and so on.
The levels of TSB were calculated in both groups and their comparison was made at every 12, 24 and 48 hrs after the start of phototherapy.
Results: The mean of total serum bilirubin on admission was 16.
01 ± 3.
91 mg / dL for the continuous group and 15.
21 ± 1.
12 mg / dL for the intermittent group.
The TSB mean after 12, 24 and 48 hrs.
for continuous phototherapy was 13.
30 ± 2.
3 mg / dl, 11.
1 ± 2.
01 mg / dl, 9.
26 ± 0.
92 mg / dl and 13.
1 ± 1.
70 mg / dL, 9.
54 ± 1.
7 mg / dL, 8.
9 ± 0.
61 mg / dl (p <0.
05) for the intermittent group, respectively.
The mean rate of decrease in serum concentration of bilirubin was 0.
30 ± 0.
14 mg / dl / h in group A and 0.
19 ± 0.
07 mg / dl / h in group B (p = 0.
5).
There was no big variance between the mean hospital stay in groups A and B (p = 0.
550).
Conclusions: Intermittent phototherapy is a better choice than continuous phototherapy in the treatment of non-haemolytic hyperbilirubinemia, with added benefits such as less frequent disruption of the mother-child relationship and reduced radiation therapy.
Keywords: Intermittent phototherapy; Continuous phototherapy; Total serum bilirubin and Neonatal hyperbilirubinemia.
Related Results
Comparison of Intermittent Versus Continuous Phototherapy in Neonatal Hyperbilirubinaemia
Comparison of Intermittent Versus Continuous Phototherapy in Neonatal Hyperbilirubinaemia
Background: Neonatal jaundice is a common condition characterized by elevated bilirubin levels, which, if untreated, can lead to severe complications such as kernicterus. Photother...
19 Treatment of Neonatal Hyperbilirubinemia – Ontario Cohort 2014-2018
19 Treatment of Neonatal Hyperbilirubinemia – Ontario Cohort 2014-2018
Abstract
Background
Serious complications that could result from severe neonatal hyperbilirubinemia include acute and chronic bi...
A study on effect of phototherapy on platelet count in neonates with unconjugated hyperbilirubinemia: a hospital based prospective observational study
A study on effect of phototherapy on platelet count in neonates with unconjugated hyperbilirubinemia: a hospital based prospective observational study
Background: Thrombocytopenia as a side effect of phototherapy has not been mentioned in standard literature and textbooks. Though there are few studies in this regard, but results ...
Double versus Single Phototherapy in the Treatment of Neonatal Hyperbilirubinemia
Double versus Single Phototherapy in the Treatment of Neonatal Hyperbilirubinemia
Background: Hyperbilirubinemia is a common problem in full-term newborns. Since the 1950s, phototherapy has been the choice of treatment for lowering bilirubin concentration in neo...
Intermittent versus continuous phototherapy among term infants presenting with non-hemolytic moderate hyperbilirubinemia at a tertiary care hospital: a randomized controlled trial.
Intermittent versus continuous phototherapy among term infants presenting with non-hemolytic moderate hyperbilirubinemia at a tertiary care hospital: a randomized controlled trial.
Objective: To compare the effectiveness of intermittent versus continuous phototherapy among term infants presenting with non-hemolytic moderate hyperbilirubinemia at a tertiary ca...
Hypocalcaemia- The detrimental effect of phototherapy.
Hypocalcaemia- The detrimental effect of phototherapy.
Background: Jaundice is the single most common abnormal physical finding in the first week of life. Jaundice is observed during the 1st week of life in approximately 60% of term in...
Hyperbilirubinemia and associated factors among neonates admitted to neonatal care unit in Jimma Medical Center
Hyperbilirubinemia and associated factors among neonates admitted to neonatal care unit in Jimma Medical Center
Abstract
Background: Neonatal hyperbilirubinemia is a widespread and significant clinical problem among neonates worldwide. Globally, every year about 1.1 million babies de...
Risk Factors of Rebound Hyperbilirubinemia in Post Phototherapy Hyperbilirubinemia Infants
Risk Factors of Rebound Hyperbilirubinemia in Post Phototherapy Hyperbilirubinemia Infants
Background: Post phototherapy rebound hyperbilirubinemia is a cause for readmission in some infants.However, this phenomenon data of rebound hyperbilirubinemia is lacking from Indo...

